The Utility of Broad Detection of Respiratory Pathogens: A PASCV E-journal Club Discussion
Tell a Friend About This EventTell a Friend
 

In this first-ever on-line journal club, three discussants will highlight important background, investigational methods, results and interpretation of an outcomes study described in “Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia “ authored by Gadsby NJ et al, in Clinical Infectious Diseases 2016;62 (7):817–23.

12/8/2016
When: 12/8/16
12:00 PM
Where: United States
Presenter: Speaker(s): Angella Charnot-Katsikas, MD, Gregory Storch, MD, Alexandra Valsamakis, MD, PhD
Contact: Karen Wolowski
412-983-1168


Online registration is closed.
« Go to Upcoming Event List  

Members:  FREE

Non-Members:  $100

 

1.0 Contact Hours

PASCV is approved as as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. Only registrants will be eligible for P.A.C.E. ® credit.

 

Moderator:
Angella Charnot-Katsikas, MD, Assistant Professor of Pathology and Assistant Medical Director,

Clinical Microbiology and Immunology Laboratories, The University of Chicago Medicine

Speaker(s):
Angella Charnot-Katsikas, MD, Assistant Professor of Pathology and Assistant Medical Director,

Clinical Microbiology and Immunology Laboratories, The University of Chicago Medicine

Gregory Storch, MD, Professor of Pediatrics, Medicine, and Molecular Microbiology; Chief,

Division of Pediatric Laboratory Medicine and Medical Director, Clinical Laboratories, St. Louis Children's Hospital, St Louis, MO

Alexandra Valsamakis, MD, PhD, Associate Professor of Pathology and Director,

Clinical Virology and Molecular Microbiology, Johns Hopkins Medicine, Baltimore, MD


Program Description:

In this first-ever on-line journal club, three discussants will highlight important background, investigational methods, results and interpretation of an outcomes study described in “Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia “ authored by Gadsby NJ et al, in Clinical Infectious Diseases 2016;62 (7):817–23.

The on-line audience can follow the discussion using audiovisuals that will include an annotated pdf of the paper. An informal discussion (~20 minutes) comprised of audience questions and comments will follow the formal discussion (~40 minutes).

 

Upon completion of this webinar, the participant should be able to :

- Describe three limitations of culture-based diagnostics in directing appropriate antibiotic utilization for the treatment of community-acquired pneumonia; 

Describe how large multiplex NAATs with quantitative capabilities affect diagnostic yield compared to culture; 

Provide examples of how large multiplex quantitative NAATs for respiratory pathogens can affect antibiotic utilization; and 

- List three critiques that could affect the findings of the discussed study.

Level of Instruction: Intermediate